Ève Tremblay

2.5k total citations
25 papers, 1.3k citations indexed

About

Ève Tremblay is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ève Tremblay has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ève Tremblay's work include Pulmonary Hypertension Research and Treatments (15 papers), Peptidase Inhibition and Analysis (5 papers) and Circular RNAs in diseases (4 papers). Ève Tremblay is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Peptidase Inhibition and Analysis (5 papers) and Circular RNAs in diseases (4 papers). Ève Tremblay collaborates with scholars based in Canada, United States and France. Ève Tremblay's co-authors include Steeve Provencher, Sébastien Bonnet, Sandra Breuils‐Bonnet, François Potus, Roxane Paulin, Jolyane Meloche, Valérie Nadeau, Colin Graydon, Olivier Boucherat and Evangelos D. Michelakis and has published in prestigious journals such as Circulation, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ève Tremblay

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ève Tremblay Canada 17 946 573 439 330 139 25 1.3k
Sandra Breuils‐Bonnet Canada 19 1.1k 1.2× 719 1.3× 492 1.1× 407 1.2× 164 1.2× 41 1.6k
Benoît Ranchoux France 14 971 1.0× 535 0.9× 423 1.0× 236 0.7× 169 1.2× 17 1.4k
Audrey Courboulin Canada 15 910 1.0× 718 1.3× 288 0.7× 499 1.5× 104 0.7× 19 1.4k
Valérie Nadeau Canada 16 554 0.6× 463 0.8× 250 0.6× 202 0.6× 122 0.9× 28 976
Loredana Ciuclan United Kingdom 14 559 0.6× 509 0.9× 217 0.5× 171 0.5× 191 1.4× 23 1.3k
Paola Caruso Italy 14 629 0.7× 690 1.2× 174 0.4× 521 1.6× 82 0.6× 37 1.3k
Raphaël Thuillet France 17 909 1.0× 318 0.6× 376 0.9× 93 0.3× 177 1.3× 42 1.3k
Fares A. Masri United States 6 596 0.6× 325 0.6× 222 0.5× 147 0.4× 70 0.5× 8 817
Weihua Li China 17 506 0.5× 351 0.6× 112 0.3× 292 0.9× 113 0.8× 74 1.0k
Sachindra Raj Joshi United States 16 334 0.4× 330 0.6× 166 0.4× 190 0.6× 73 0.5× 35 769

Countries citing papers authored by Ève Tremblay

Since Specialization
Citations

This map shows the geographic impact of Ève Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ève Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ève Tremblay more than expected).

Fields of papers citing papers by Ève Tremblay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ève Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ève Tremblay. The network helps show where Ève Tremblay may publish in the future.

Co-authorship network of co-authors of Ève Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Ève Tremblay. A scholar is included among the top collaborators of Ève Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ève Tremblay. Ève Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimauchi, Tsukasa, Olivier Boucherat, Tetsuro Yokokawa, et al.. (2022). PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension. JACC Basic to Translational Science. 7(4). 384–403. 26 indexed citations
2.
Wu, Wenhui, Karima Habbout, Sandra Breuils‐Bonnet, et al.. (2021). R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models. European Respiratory Journal. 57(5). 2003271–2003271. 7 indexed citations
3.
Wu, Wenhui, Sébastien Bonnet, Tsukasa Shimauchi, et al.. (2021). Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension. Thorax. 77(3). 247–258. 16 indexed citations
4.
Shimauchi, Tsukasa, Wenhui Wu, Junichi Omura, et al.. (2021). Abstract 10231: Parp1-Pkm2 Axis Mediates Right Ventricular Failure Associated with Pulmonary Arterial Hypertension. Circulation. 144(Suppl_1). 3 indexed citations
5.
Bourgeois, Alice, Valérie Nadeau, Mark Orcholski, et al.. (2021). Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 22(6). 2919–2919. 12 indexed citations
6.
Habbout, Karima, Junichi Omura, Alice Bourgeois, et al.. (2021). Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach. International Journal of Molecular Sciences. 22(6). 2957–2957. 12 indexed citations
7.
Vitry, Géraldine, Roxane Paulin, Marie-Claude Lampron, et al.. (2020). Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 203(5). 614–627. 25 indexed citations
8.
Lampron, Marie-Claude, Géraldine Vitry, Valérie Nadeau, et al.. (2020). PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 40(3). 783–801. 19 indexed citations
9.
Feen, Diederik E. van der, Kondababu Kurakula, Ève Tremblay, et al.. (2019). Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 200(7). 910–920. 96 indexed citations
10.
Bourgeois, Alice, Sébastien Bonnet, Sandra Breuils‐Bonnet, et al.. (2019). Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 39(8). 1667–1681. 36 indexed citations
11.
Boucherat, Olivier, Alice Bourgeois, Valérie Nadeau, et al.. (2018). Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 198(1). 90–103. 79 indexed citations
12.
Meloche, Jolyane, Marie-Claude Lampron, Valérie Nadeau, et al.. (2017). Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 37(8). 1513–1523. 70 indexed citations
13.
Meloche, Jolyane, François Potus, Benoît Ranchoux, et al.. (2015). miR-223 reverses experimental pulmonary arterial hypertension. American Journal of Physiology-Cell Physiology. 309(6). C363–C372. 102 indexed citations
14.
Potus, François, Grégoire Ruffenach, Abdellaziz Dahou, et al.. (2015). Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 132(10). 932–943. 168 indexed citations
15.
Meloche, Jolyane, François Potus, Mylène Vaillancourt, et al.. (2015). Bromodomain-Containing Protein 4. Circulation Research. 117(6). 525–535. 133 indexed citations
16.
Potus, François, Simon Malenfant, Colin Graydon, et al.. (2014). Impaired Angiogenesis and Peripheral Muscle Microcirculation Loss Contribute to Exercise Intolerance in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 190(3). 318–328. 103 indexed citations
17.
Malenfant, Simon, François Potus, Frédéric Fournier, et al.. (2014). Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension. Journal of Molecular Medicine. 93(5). 573–584. 59 indexed citations
18.
Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2013). Role for DNA Damage Signaling in Pulmonary Arterial Hypertension. Circulation. 129(7). 786–797. 198 indexed citations
19.
Courboulin, Audrey, Marjorie Barrier, Pierre Bonnet, et al.. (2012). Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. European Respiratory Journal. 40(3). 618–629. 56 indexed citations
20.
Tremblay, Pierrot, et al.. (2011). Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. The Journal of Pathology. 224(2). 222–233. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Breuils‐Bonnet Breakdown of academic impact, for papers by Benoît Ranchoux Breakdown of academic impact, for papers by Audrey Courboulin Breakdown of academic impact, for papers by Valérie Nadeau Breakdown of academic impact, for papers by Loredana Ciuclan Breakdown of academic impact, for papers by Paola Caruso Breakdown of academic impact, for papers by Raphaël Thuillet Breakdown of academic impact, for papers by Fares A. Masri Breakdown of academic impact, for papers by Weihua Li Breakdown of academic impact, for papers by Sachindra Raj Joshi
Rankless by CCL
2026